Magellan Health Reports Second Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
- Qualcomm shares fall on Intel warning and legal concerns
- Marvell Technology shares drop on Lumentum deal concerns
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Oracle shares drop on AI spending concerns and Microsoft criticism
- SpaceX stock drops on launch setback and sector selloff
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
Magellan Health (MGLN) Misses Q2 EPS by 31c, Miss on Revenues; Lowers FY18 EPS/Revenue Outlook
July 27, 2018 6:35 AM EDTMagellan Health (NASDAQ: MGLN) reported Q2 EPS of $0.92, $0.31 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $1.81 billion versus the consensus estimate of $1.88 billion.
Highlights Include:
Net revenue increased 27.6 percent over the second quarter of 2017 to $1.8 billion.Net income increased 146.4 percent over the second quarter of 2017 to $13.6 million.Segment profit increased 25.2 percent over the second quarter of 2017 to $68.0 million.Adjusted net income increased 65.2 percent from the second quarter of 2017 to $23.3 million.Unrestricted cash and investments were $244.4 million as of June 30, 2018. Approximately $115.8... More


